Table: begin end state 1 14 cytoplasmic 15 37 transmembrane 38 42 non-cytoplasmic 43 59 transmembrane 60 70 cytoplasmic 71 88 transmembrane 89 94 non-cytoplasmic 95 121 transmembrane 122 127 cytoplasmic 128 146 transmembrane 147 171 non-cytoplasmic 172 193 transmembrane 194 215 cytoplasmic 216 242 transmembrane 243 276 non-cytoplasmic 277 305 transmembrane 306 338 cytoplasmic 339 357 transmembrane 358 362 non-cytoplasmic 363 381 transmembrane 382 391 cytoplasmic 392 418 transmembrane 419 437 non-cytoplasmic 438 457 transmembrane 458 462 cytoplasmic 463 484 transmembrane 485 488 non-cytoplasmic 489 514 transmembrane 515 524 cytoplasmic 525 551 transmembrane 552 559 non-cytoplasmic 560 581 transmembrane 582 593 cytoplasmic 594 620 transmembrane 621 639 non-cytoplasmic
Input: >3608896 FitnessBrowser__Dino:3608896 MNQPATIPVANPAPAGGLGAPLGGLFALLVICVIAFATLDEATARFGAIALSVAIVGLAH PARRGRPSGRAVDAALLAGFGCAGWWFHAVKAELWTGFFVATPLSVLAGLAGVFTVIVLA ARVWGRSLAILAGALILYAFGGPYLPNAVAHFGVGLGDFVQITWYSFDGVFGRMTGLVAS NLLIFLILGAVLQQTGAGESLIRLSTALLGRVRGGGAHAAIAASAVFGMMNGSVAANIAG TGVFTIPMIKRQGFSSRFAGAVEAAASSGGQLTPPIMAATVFVMADLVGLPLLMVIAAAA LPALFKYLGLFAQVYVEALRLDIRPLAAEDIPKLTRQDWLQSALVLVPLAVLMIAFLSGS SPAMAGLAGTIAALVTGLVLTPQLRQQPIRIWWALCAGGLASARILLSVAVIGIVLAVVN ETGIAIRFAVALSEVGDAYLPLALLMAMLGALVLGMGLPTLPAYLIVAIMIVPTLIEAGV LPLAAHMFVLYFAVFSSIMPPIAYGCFVAAPIAGADALRISFTALRISIVGLIVPFAFVY APSLLLVAGSFSWAELLTTALRLSLASWLLATALGGADPVLGRLPRHNRMLRGGAACAVM VPTVALWGPGLALGIAMGVLHPLHRAGWIKRVSLRAHGT
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server